These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24604209)

  • 1. A high-affinity near-infrared fluorescent probe to target bombesin receptors.
    Shrivastava A; Ding H; Kothandaraman S; Wang SH; Gong L; Williams M; Milum K; Zhang S; Tweedle MF
    Mol Imaging Biol; 2014 Oct; 16(5):661-9. PubMed ID: 24604209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and in Vitro and in Vivo Evaluation of High Affinity and Specificity Near-Infrared Fluorescent Bombesin Antagonists for Tumor Imaging.
    Xu H; Bandari RP; Lee L; Li R; Yu P; Smith CJ; Ma L
    J Med Chem; 2018 Sep; 61(17):7657-7670. PubMed ID: 30111088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer.
    Pagoto A; Garello F; Marini GM; Tripepi M; Arena F; Bardini P; Stefania R; Lanzardo S; Valbusa G; Porpiglia F; Manfredi M; Aime S; Terreno E
    Mol Imaging Biol; 2020 Feb; 22(1):85-93. PubMed ID: 31025163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP; Jiang Z; Reynolds TS; Bernskoetter NE; Szczodroski AF; Bassuner KJ; Kirkpatrick DL; Rold TL; Sieckman GL; Hoffman TJ; Connors JP; Smith CJ
    Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
    Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
    Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterobivalent dual-target probe for targeting GRP and Y1 receptors on tumor cells.
    Shrivastava A; Wang SH; Raju N; Gierach I; Ding H; Tweedle MF
    Bioorg Med Chem Lett; 2013 Feb; 23(3):687-92. PubMed ID: 23265893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human GRPr-transfected Ace-1 canine prostate cancer model in mice.
    Ding H; Kothandaraman S; Gong L; Williams MM; Dirksen WP; Rosol TJ; Tweedle MF
    Prostate; 2016 Jun; 76(9):783-95. PubMed ID: 26940014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
    Ma L; Yu P; Veerendra B; Rold TL; Retzloff L; Prasanphanich A; Sieckman G; Hoffman TJ; Volkert WA; Smith CJ
    Mol Imaging; 2007; 6(3):171-80. PubMed ID: 17532883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
    Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
    Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots.
    Hu K; Wang H; Tang G; Huang T; Tang X; Liang X; Yao S; Nie D
    J Nucl Med; 2015 Aug; 56(8):1278-84. PubMed ID: 26112023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z; Yan Y; Liu S; Wang F; Chen X
    Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
    J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Mouse and Human Serum Stability of a Heterobivalent Dual-Target Probe That Has Strong Affinity to Gastrin-Releasing Peptide and Neuropeptide Y1 Receptors on Tumor Cells.
    Ghosh A; Raju N; Tweedle M; Kumar K
    Cancer Biother Radiopharm; 2017 Feb; 32(1):24-32. PubMed ID: 28186846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector.
    Abd-Elgaliel WR; Gallazzi F; Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Lever SZ
    Bioconjug Chem; 2008 Oct; 19(10):2040-8. PubMed ID: 18808168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
    Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ
    Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fast tumor-targeting near-infrared fluorescent probe based on bombesin analog for in vivo tumor imaging.
    Chen H; Wan S; Zhu F; Wang C; Cui S; Du C; Ma Y; Gu Y
    Contrast Media Mol Imaging; 2014; 9(2):122-34. PubMed ID: 24523057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.